Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

Data-driven insights powered by advanced analytics and artificial intelligence (AI) help optimise project schedules, allocate ...

Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...

Pharmaceutical manufacturing is a key component of Purdue’s One Health initiative, which advances knowledge and innovation related to animal, human and environmental health and well-being through ...

Entering 2025, the CDMO industry is at a crossroads. Reflecting on conversations over the past year—with CEOs navigating ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

The global pharmaceutical industry is valued at approximately $1.6 trillion, while India's market stands at $55 billion, ...

This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

U.S. President Donald Trump’s threats to slap tariffs on medicines could rattle an industry that has become a cornerstone of ...

Sudair Pharma aims to localise insulin production, contributing to the continuity of supply and reducing reliance on imports ...

Germany has very big problems. This is reported by the specialists of the statistical office Destatis, who published the ...